Literature DB >> 28578223

SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs.

Lihua Shii1, Li Song2, Kelly Maurer3, Zhe Zhang4, Kathleen E Sullivan5.   

Abstract

The SERPINB2 gene is strongly upregulated in inflammatory states. In monocytes, it can constitute up to 1% of total cellular protein. It functions in protection from proteotoxic stress and plays a role in angioedema. The purpose of this study was to define the roles of enhancer RNAs embedded in the SERPIN gene complex. We found that the upstream enhancer RNAs upregulated SERPINB2 and the enhancer RNAs were expressed prior to those of SERPINB2 mRNA. Studies of the SERPINB2 promoter demonstrated the presence of an RNA polymerase II pause-inducing protein, NELF. Stimulation with LPS led to recruitment of the pause-releasing kinase P-TEFb and departure of the pause-inducing protein NELF. RNA immunoprecipitation revealed that NELF and the CDK9 component of P-TEFb bound to the enhancer RNAs after stimulation with distinct kinetics. Knock-down of the enhancer RNAs compromised stimulus induction of promoter and enhancer chromatin changes. Conversely, over-expression was associated with enhanced recruitment of c-JUN and increased expression of SERPINB2 mRNA expression. This study is the first to associate enhancer RNAs with SERPINB2 and is the first demonstration of acquisition of NELF binding by enhancer RNAs on chromatin.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CDK9; Histone modifications; NELF; P-TEFb; PAI-2; eRNA

Mesh:

Substances:

Year:  2017        PMID: 28578223      PMCID: PMC5535806          DOI: 10.1016/j.molimm.2017.05.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  65 in total

1.  Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.

Authors:  Greg Foltz; Gi-Yung Ryu; Jae-Geun Yoon; Timothy Nelson; Jessica Fahey; Amanda Frakes; Hwahyung Lee; Lorie Field; Kaitlin Zander; Zita Sibenaller; Timothy C Ryken; Rajeev Vibhakar; Leroy Hood; Anup Madan
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

2.  Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters.

Authors:  Leighton J Core; Joshua J Waterfall; John T Lis
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

3.  Polarization of primary human monocytes by IFN-gamma induces chromatin changes and recruits RNA Pol II to the TNF-alpha promoter.

Authors:  Stacey Garrett; Kelly Dietzmann-Maurer; Li Song; Kathleen E Sullivan
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

4.  Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells.

Authors:  Irene M Min; Joshua J Waterfall; Leighton J Core; Robert J Munroe; John Schimenti; John T Lis
Journal:  Genes Dev       Date:  2011-04-01       Impact factor: 11.361

5.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.

Authors:  T Wada; T Takagi; Y Yamaguchi; A Ferdous; T Imai; S Hirose; S Sugimoto; K Yano; G A Hartzog; F Winston; S Buratowski; H Handa
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

6.  SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication.

Authors:  Grant A Darnell; Wayne A Schroder; Joy Gardner; David Harrich; Hong Yu; Robert L Medcalf; David Warrilow; Toni M Antalis; Secondo Sonza; Andreas Suhrbier
Journal:  J Biol Chem       Date:  2006-08-21       Impact factor: 5.157

7.  Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.

Authors:  Samir Rahman; Cornelia E Zorca; Tatiana Traboulsi; Emmanuel Noutahi; Matthew R Krause; Sylvie Mader; Daniel Zenklusen
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

8.  The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.

Authors:  Ekemini A Udofa; Brett W Stringer; Padmaja Gade; Donna Mahony; Marguerite S Buzza; Dhananjaya V Kalvakolanu; Toni M Antalis
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

9.  HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription.

Authors:  Xavier Contreras; Matjaz Barboric; Tina Lenasi; B Matija Peterlin
Journal:  PLoS Pathog       Date:  2007-10-12       Impact factor: 6.823

10.  Integrator mediates the biogenesis of enhancer RNAs.

Authors:  Fan Lai; Alessandro Gardini; Anda Zhang; Ramin Shiekhattar
Journal:  Nature       Date:  2015-08-26       Impact factor: 49.962

View more
  12 in total

Review 1.  SERPINB2-its regulation and interplay with aryl hydrocarbon receptor.

Authors:  Damian Brauze
Journal:  J Appl Genet       Date:  2021-01-02       Impact factor: 3.240

2.  Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.

Authors:  Joo-Hyung Lee; Feng Xiong; Wenbo Li
Journal:  RNA Biol       Date:  2020-01-19       Impact factor: 4.652

Review 3.  Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.

Authors:  Jeroen Kneppers; Andries M Bergman; Wilbert Zwart
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1.

Authors:  Lihua Shi; Song Li; Kelly Maurer; Zhe Zhang; Michelle Petri; Kathleen E Sullivan
Journal:  Mol Immunol       Date:  2018-10-20       Impact factor: 4.407

5.  IL-1 Transcriptional Responses to Lipopolysaccharides Are Regulated by a Complex of RNA Binding Proteins.

Authors:  Lihua Shi; Li Song; Kelly Maurer; Ying Dou; Vishesh R Patel; Chun Su; Michelle E Leonard; Sumei Lu; Kenyaita M Hodge; Annabel Torres; Alessandra Chesi; Struan F A Grant; Andrew D Wells; Zhe Zhang; Michelle A Petri; Kathleen E Sullivan
Journal:  J Immunol       Date:  2020-01-17       Impact factor: 5.422

Review 6.  Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment.

Authors:  Mengting Ding; Yuhan Liu; Xinhui Liao; Hengji Zhan; Yuchen Liu; Weiren Huang
Journal:  J Cancer       Date:  2018-06-06       Impact factor: 4.207

Review 7.  Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate.

Authors:  Preston R Arnold; Andrew D Wells; Xian C Li
Journal:  Front Cell Dev Biol       Date:  2020-01-14

Review 8.  Enhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis.

Authors:  Emmanuel Odame; Yuan Chen; Shuailong Zheng; Dinghui Dai; Bismark Kyei; Siyuan Zhan; Jiaxue Cao; Jiazhong Guo; Tao Zhong; Linjie Wang; Li Li; Hongping Zhang
Journal:  Cell Mol Biol Lett       Date:  2021-02-10       Impact factor: 5.787

Review 9.  Enhancer RNA: What we know and what we can achieve.

Authors:  Zhenzhen Han; Wei Li
Journal:  Cell Prolif       Date:  2022-02-16       Impact factor: 8.755

10.  Auxin-degron system identifies immediate mechanisms of OCT4.

Authors:  Lawrence E Bates; Mariana R P Alves; José C R Silva
Journal:  Stem Cell Reports       Date:  2021-06-17       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.